FibroBiologics Revenue and Competitors
Estimated Revenue & Valuation
- FibroBiologics's estimated annual revenue is currently $1.2M per year.
- FibroBiologics's estimated revenue per employee is $77,500
Employee Data
- FibroBiologics has 15 Employees.
- FibroBiologics grew their employee count by 25% last year.
FibroBiologics's People
Name | Title | Email/Phone |
---|---|---|
1 | Chairman/CEO/Founder | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Interim Chief Financial Officer | Reveal Email/Phone |
4 | Chief Scientific Officer | Reveal Email/Phone |
5 | General Counsel | Reveal Email/Phone |
6 | Associate Scientist, Cell Line Development | Reveal Email/Phone |
7 | General Counsel | Reveal Email/Phone |
8 | Research Specialist | Reveal Email/Phone |
FibroBiologics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.5M | 16 | 45% | N/A | N/A |
#2 | $13.8M | 89 | -7% | N/A | N/A |
#3 | $18.6M | 120 | 3% | $1.8M | N/A |
#4 | $0.9M | 6 | -40% | N/A | N/A |
#5 | $4.2M | 27 | 0% | N/A | N/A |
#6 | $3.4M | 22 | 47% | N/A | N/A |
#7 | $9.6M | 62 | 29% | N/A | N/A |
#8 | $0.9M | 6 | 20% | N/A | N/A |
#9 | $1.7M | 11 | 10% | N/A | N/A |
#10 | $15.2M | 98 | -8% | N/A | N/A |
What Is FibroBiologics?
FibroBiologics is the world leader in cell therapy using fibroblasts to regenerate tissue and cure chronic diseases. Currently, FibroBiologics holds 150+ U.S. and international issued patents issued/pending across a variety of clinical pathways, including Disc Degeneration, Multiple Sclerosis, and Cancer. FibroBiologics represents the next generation of medical advancement in cell therapy.
keywords:N/AN/A
Total Funding
15
Number of Employees
$1.2M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 15 | -6% | N/A |
#2 | $3.8M | 15 | N/A | N/A |
#3 | $1.3M | 15 | 25% | N/A |
#4 | $2.2M | 15 | 7% | N/A |
#5 | $3M | 15 | -21% | N/A |